
Guardant Health Appoints Alex M. Azar II to Board of Directors
Alex M. Azar II Joins Guardant Health Board of Directors, Bringing Deep Public and Private Sector Leadership to Advance Precision Oncology Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that Alex M. Azar II, former U.S.…












